sch 23982 has been researched along with apomorphine in 2 studies
Studies (sch 23982) | Trials (sch 23982) | Recent Studies (post-2010) (sch 23982) | Studies (apomorphine) | Trials (apomorphine) | Recent Studies (post-2010) (apomorphine) |
---|---|---|---|---|---|
87 | 0 | 0 | 9,205 | 287 | 780 |
Protein | Taxonomy | sch 23982 (IC50) | apomorphine (IC50) |
---|---|---|---|
Tryptophan 5-hydroxylase 1 | Rattus norvegicus (Norway rat) | 0.22 | |
D(2) dopamine receptor | Homo sapiens (human) | 0.0146 | |
Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 7.75 | |
D | Rattus norvegicus (Norway rat) | 0.4744 | |
D(3) dopamine receptor | Rattus norvegicus (Norway rat) | 0.1432 | |
Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.063 | |
D(2) dopamine receptor | Bos taurus (cattle) | 0.3385 | |
D(1A) dopamine receptor | Homo sapiens (human) | 0.025 | |
D(4) dopamine receptor | Homo sapiens (human) | 0.025 | |
D(1B) dopamine receptor | Homo sapiens (human) | 0.025 | |
Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | 0.063 | |
Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.063 | |
Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 7.75 | |
D(1B) dopamine receptor | Rattus norvegicus (Norway rat) | 0.1432 | |
D(4) dopamine receptor | Rattus norvegicus (Norway rat) | 0.1432 | |
D(3) dopamine receptor | Homo sapiens (human) | 0.025 | |
Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 7.75 | |
D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.0813 | |
E3 ubiquitin-protein ligase Mdm2 | Homo sapiens (human) | 0.205 | |
5-hydroxytryptamine receptor 4 | Rattus norvegicus (Norway rat) | 1.35 | |
D | Bos taurus (cattle) | 0.3385 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adams, EF; Fahlbusch, R; Nomikos, P; Reif, M; Schrell, UM | 1 |
Ackerman, M; Artman, LD; Asin, KE; Bednarz, L; Johnson, MC; Kebabian, JW; Kerkman, DJ; MacKenzie, RG; Montana, W; Stampfli, H | 1 |
2 other study(ies) available for sch 23982 and apomorphine
Article | Year |
---|---|
Growth of cultured human cerebral meningiomas is inhibited by dopaminergic agents. Presence of high affinity dopamine-D1 receptors.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Apomorphine; Benzazepines; Binding, Competitive; Bromocriptine; Butaclamol; Cell Division; Dopamine; Dopamine Agents; Humans; Meningioma; Receptors, Dopamine; Receptors, Dopamine D1; Tumor Cells, Cultured | 1990 |
A-69024: a non-benzazepine antagonist with selectivity for the dopamine D-1 receptor.
Topics: Adenylyl Cyclases; Animals; Apomorphine; Benzazepines; Binding, Competitive; Catalepsy; Dihydroxyphenylalanine; Haloperidol; Injections, Subcutaneous; Iodine Radioisotopes; Male; Motor Activity; Papaverine; Prolactin; Rats; Rats, Inbred Strains; Receptors, Dopamine; Stereotyped Behavior; Tetrahydroisoquinolines | 1989 |